New Cytometry Technique for Characterizing Viral Vectors

Kite Pharma, a Gilead Company, has developed a technique for analyzing individual lentiviral vector particles, which it hopes will allow better characterization of future in vivo CAR T therapy products than traditional Western blotting. “The virus is going to be our product, and we want to have the deepest understanding we can have of that,” … New Cytometry Technique for Characterizing Viral…